Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk.
Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk.
复制标题
DOI:
10.2337/db11-0729
复制
发表时间:
2011-12
期刊:
影响因子:
7.7
通讯作者:
Ziegler AG
中科院分区:
文献类型:
--
作者:
Bonifacio E;Warncke K;Winkler C;Wallner M;Ziegler AG
The incidence of type 1 diabetes is increasing. Delivery by cesarean section is also more prevalent, and it is suggested that cesarean section is associated with type 1 diabetes risk. We examine associations between cesarean delivery, islet autoimmunity and type 1 diabetes, and genes involved in type 1 diabetes susceptibility. Cesarean section was examined as a risk factor in 1,650 children born to a parent with type 1 diabetes and followed from birth for the development of islet autoantibodies and type 1 diabetes. Children delivered by cesarean section (n = 495) had more than twofold higher risk for type 1 diabetes than children born by vaginal delivery (hazard ratio [HR] 2.5; 95% CI 1.4–4.3; P = 0.001). Cesarean section did not increase the risk for islet autoantibodies (P = 0.6) but was associated with a faster progression to diabetes after the appearance of autoimmunity (P = 0.015). Cesarean section–associated risk was independent of potential confounder variables (adjusted HR 2.7;1.5–5.0; P = 0.001) and observed in children with and without high-risk HLA genotypes. Interestingly, cesarean section appeared to interact with immune response genes, including CD25 and in particular the interferon-induced helicase 1 gene, where increased risk for type 1 diabetes was only seen in children who were delivered by cesarean section and had type 1 diabetes–susceptible IFIH1 genotypes (12-year risk, 9.1 vs. <3% for all other combinations; P < 0.0001). These findings suggest that type 1 diabetes risk modification by cesarean section may be linked to viral responses in the preclinical autoantibody-positive disease phase.
登录
查看更多内容
影响因子:
7.7
作者:
Lipponen K;Gombos Z;Kiviniemi M;Siljander H;Lempainen J;Hermann R;Veijola R;Simell O;Knip M;Ilonen J
通讯作者:
Ilonen J
DOI:
10.1136/bmj.c5065
发表时间:
2010-10-06
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Bragg F;Cromwell DA;Edozien LC;Gurol-Urganci I;Mahmood TA;Templeton A;van der Meulen JH
通讯作者:
van der Meulen JH
影响因子:
8.2
作者:
Gale, EAM
通讯作者:
Gale, EAM
影响因子:
2.5
作者:
Huurre, Anu;Kalliomaki, Marko;Isolauri, Erika
通讯作者:
Isolauri, Erika
影响因子:
16.2
作者:
PATTERSON, CC;WAUGH, NR;HADDEN, DR
通讯作者:
HADDEN, DR